ELDN
Eledon Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$300.26M
P/E Ratio
—
EPS
$-0.77
Beta
0.95
52W High
$4.60
52W Low
$1.35
50-Day MA
$3.41
200-Day MA
$2.63
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
5.39
PEG Ratio
—
About Eledon Pharmaceuticals Inc
Eledon Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing drugs for patients living with autoimmune diseases and amyotrophic lateral sclerosis (ALS) who require organ or cell transplantation. The company is headquartered in Irvine, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-36.86M |
| Operating Margin | 0.00% |
| Return on Equity | -72.70% |
| Return on Assets | -35.10% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.32 |
| Price-to-Book | 6.72 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 0.84 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $77.19M |
| Float | $69.93M |
| % Insiders | 1.09% |
| % Institutions | 59.23% |
Historical Volatility
HV 10-Day
55.89%
HV 20-Day
52.36%
HV 30-Day
70.54%
HV 60-Day
70.35%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($8.20 target)
7
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026